Effects of β-lactam antibiotics on development of tolerance and dependence to morphine

Yaoxue Xuebao

Volumn 43, Issue 11, 2008, Pages 1094-1098

  Wang, Meng ^a   Dong, Hua Jin ^a   Gong, Ze Hui ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

lactam antibiotic; Dependence; Morphine; Tolerance

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTRIAXONE; MORPHINE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; MORPHINE ADDICTION; MOUSE; PAIN THRESHOLD; PATHOPHYSIOLOGY; RANDOMIZATION; WITHDRAWAL SYNDROME;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEFTRIAXONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; MICE; MORPHINE; MORPHINE DEPENDENCE; PAIN THRESHOLD; RANDOM ALLOCATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 56649123108     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gui LL, Zhang CH. Glu translator and morphine's dependance and tolorence [J]. Chin J Drug Depend, 2007,16:2-4.
2. Yu XC. Relationship between glutamate transporter, glutamate/cysteine transporter and neurotoxicity induced by glutamate [J]. Chin J Clin Pharmcol Ther, 2003,8:490-493.
3. Raith K, Hochhaus G. Drugs used in the treatment of opioid tolerance and physical dependence: review [J]. J Clin Pharmacol Ther, 2004,42:191-203.
4. Lindar W, Mark RH, Ian NJ, et al. Glia: novel counter-regulators of opioid analgesia [J]. Trends Neurosci, 2005,28:661-669.
5. Miller TM, Cleveland DW. Treating neurodegenerative diseases with antibiotics [J]. Science, 2005,307:361-362.
6. Mao JR. Glutamate transporter: an unexpected target for some antibiotics [J]. Molecular Pain, 2005,1:5-6.
7. Rothstein JD, Patel S, Regan MR, et al. β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression [J]. Nature, 2005,433:73-77.
8. Snyder SH. Opiate receptors and beyond: 30 years of neural signaling reseach [J]. Neuropharmacology, 2004,47(Suppl. 271):274-280.
9. Ozawa T, Nakagawa T, Shige K, et al. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal [J]. Brain Res, 2001,905:254-258.
10. Salter MW. Cellular signalling pathways of spinal pain neuroplasticity as targets for analgesic development [J]. Curr Top Med Chem, 2005,5:557-567.
11. Zhang YP, Su HD. Pharmacology Experiment [M]. 2rd. Beijing: People's Medical Publishing House, 1996:49-50.
12. Gaillard JL, Abadie V, Cheron G, et al. Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy [J]. Antimicrob Agents Chemother, 1994,38:1209-1210.
13. Bruckner O, Collmann H, Hoffmann HG. Cefotaxime in treatment of meningitis and ventriculitis? Evaluation of drug concentrations in human cerebrospinal fluid [J]. Intensive Care Med, 1982,8:33-38.
14. Fong IW, Tomkins KB. Penetration of ceftrazidime into the cetebropinal fluid of patients with and without evidence of meningeal inflammation [J]. Antimicrob Agents Chemother, 1984,26:115-116.
15. Nau R, Prange HW, Muth P, et al. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges [J]. Antimicrob Agents Chemother, 1993,37:1518-1524.